Pacira | PCRX - EPS Earnings Per Share



Pacira reported $0.74 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.66 0.79 Oct/30 2025
FY2025Q2 Jun/2025 0.74 0.68 0.89 Aug/05 2025
FY2025Q1 Mar/2025 0.62 0.61 0.62 May/08 2025
FY2024Q4 Dec/2024 0.91 0.79 0.89 Feb/27 2025
FY2024Q3 Sep/2024 0.79 0.70 0.72 Nov/06 2024
FY2024Q2 Jun/2024 0.89 0.69 0.78 Jul/30 2024
FY2024Q1 Mar/2024 0.62 0.62 0.53 May/07 2024
FY2023Q4 Dec/2023 0.89 0.88 0.8 Feb/29 2024
FY2023Q3 Sep/2023 0.72 0.78 0.64 Nov/02 2023
FY2023Q2 Jun/2023 0.78 0.77 0.51 Aug/02 2023
FY2023Q1 Mar/2023 0.53 0.62 0.64 May/03 2023
FY2022Q4 Dec/2022 0.80 0.82 0.97 Feb/28 2023


Eps Change Date
Astellas Pharma JPY 38.22 3.62 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Ironwood Pharmaceuticals USD 0.14 0.12 Jun/2025
J&J USD 2.77 0 Jun/2025
Ligand Pharmaceuticals USD 1.6 0.27 Jun/2025
Novo Nordisk 5.96 0.57 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
Perrigo USD 0.57 0.03 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Supernus Pharmaceuticals USD 0.4 0.61 Jun/2025
Teva Pharmaceutical Industries USD 2.22 0.34 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025
Zoetis USD 1.76 0.28 Jun/2025